BRPI0819307A2 - Polimorfos de um inibidor do c-met/hgfr - Google Patents

Polimorfos de um inibidor do c-met/hgfr

Info

Publication number
BRPI0819307A2
BRPI0819307A2 BRPI0819307A BRPI0819307A2 BR PI0819307 A2 BRPI0819307 A2 BR PI0819307A2 BR PI0819307 A BRPI0819307 A BR PI0819307A BR PI0819307 A2 BRPI0819307 A2 BR PI0819307A2
Authority
BR
Brazil
Prior art keywords
polymorphs
met
hgfr inhibitor
hgfr
inhibitor
Prior art date
Application number
Other languages
English (en)
Inventor
Benjamin Micah Collman
Jingrong Jean Cui
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0819307A2 publication Critical patent/BRPI0819307A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0819307 2007-11-29 2008-11-18 Polimorfos de um inibidor do c-met/hgfr BRPI0819307A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99116907P 2007-11-29 2007-11-29
PCT/IB2008/003170 WO2009068955A2 (en) 2007-11-29 2008-11-18 Polymorphs of a c-met/hgfr inhibitor

Publications (1)

Publication Number Publication Date
BRPI0819307A2 true BRPI0819307A2 (pt) 2015-05-12

Family

ID=40405077

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819307 BRPI0819307A2 (pt) 2007-11-29 2008-11-18 Polimorfos de um inibidor do c-met/hgfr

Country Status (15)

Country Link
US (1) US20110039856A1 (pt)
EP (1) EP2227473A2 (pt)
JP (1) JP2009132714A (pt)
KR (1) KR20100085142A (pt)
CN (1) CN101878215A (pt)
AR (1) AR069491A1 (pt)
AU (1) AU2008331278A1 (pt)
BR (1) BRPI0819307A2 (pt)
CA (1) CA2706430A1 (pt)
IL (1) IL205756A0 (pt)
MX (1) MX2010005867A (pt)
RU (1) RU2446168C2 (pt)
TW (1) TW200927120A (pt)
WO (1) WO2009068955A2 (pt)
ZA (1) ZA201004027B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012042421A1 (en) 2010-09-29 2012-04-05 Pfizer Inc. Method of treating abnormal cell growth
UY34329A (es) 2011-09-15 2013-04-30 Novartis Ag Compuestos de triazolopiridina
WO2014073989A1 (en) * 2012-11-12 2014-05-15 Callaghan Innovation Research Limited Salt and polymorphic forms of (3r,4s)-l-((4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(mtdia)
CN105367588B (zh) * 2015-12-09 2018-09-11 上海宣创生物科技有限公司 一种三唑并吡嗪衍生物c晶型及其制备方法
EP3398951B1 (en) * 2015-12-31 2021-04-07 Shanghai Pharmaceuticals Holding Co., Ltd. Salt of quinolone compound, polymorphs thereof, preparation method therefor, composition, and applications
CN108570053A (zh) * 2017-03-13 2018-09-25 中国科学院上海药物研究所 五元并六元杂环化合物、制备方法、中间体、组合和应用
EA201992200A1 (ru) * 2017-03-17 2020-03-12 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Микроинкапсулированные композиции ингибиторов нитрификации
MX2021006982A (es) * 2018-12-14 2021-09-10 Beta Pharma Inc Compuestos sustituidos con organofosforo como inhibidores de c met, y usos terapeuticos de los mismos.
EP3942045A1 (en) 2019-03-21 2022-01-26 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2000613C2 (nl) * 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.

Also Published As

Publication number Publication date
RU2010121647A (ru) 2011-12-10
EP2227473A2 (en) 2010-09-15
MX2010005867A (es) 2010-06-11
KR20100085142A (ko) 2010-07-28
JP2009132714A (ja) 2009-06-18
CA2706430A1 (en) 2009-06-04
AR069491A1 (es) 2010-01-27
TW200927120A (en) 2009-07-01
IL205756A0 (en) 2010-11-30
ZA201004027B (en) 2011-03-30
AU2008331278A1 (en) 2009-06-04
CN101878215A (zh) 2010-11-03
WO2009068955A3 (en) 2010-05-27
WO2009068955A2 (en) 2009-06-04
US20110039856A1 (en) 2011-02-17
RU2446168C2 (ru) 2012-03-27

Similar Documents

Publication Publication Date Title
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
BRPI0819307A2 (pt) Polimorfos de um inibidor do c-met/hgfr
DK1963302T3 (da) Polymorfer af en C-MET/HGFR-inhibitor
NO347644B1 (no) Polymorfer
DK2089364T3 (da) Pyridinonforbindelser
BRPI0813500A2 (pt) Compostos antivirais
ATE502948T1 (de) Substituierte bicyclolactamverbindungen
BRPI0821086A2 (pt) Compostos inseticidas
BRPI0815042A2 (pt) Compostos de pirazol
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
BRPI0908353A2 (pt) Compostos
ATE524477T1 (de) Aziridinylepothilonverbindungen
BRPI0811264A2 (pt) Compostos
BRPI0820677A2 (pt) Misturas de compostos pesticidas
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0720097A2 (pt) Compostos de fosfonato
BRPI0809996A2 (pt) Compostos
BRPI0916432A2 (pt) compostos
BRPI0815181A2 (pt) Compostos
BRPI0821567A2 (pt) Misturas de compostos pesticidas
BRPI0820650A2 (pt) Misturas de compostos pesticidas
DK2206698T3 (da) Ethynylindolforbindelser
BRPI0922152A2 (pt) Compostos
BRPI0814613A2 (pt) Compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.